Craig Hallum resumed coverage on DiaMedica Therapeutics with a new price target

4/24/24 8:38:29 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

Craig Hallum resumed coverage of DiaMedica Therapeutics with a rating of Buy and set a new price target of $8.00

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$DMAC

Date	Price Target	Rating	Analyst
10/7/2024	$7.00	Buy	H.C. Wainwright
4/24/2024	$8.00	Buy	Craig Hallum
6/22/2023	$7.00	Perform → Outperform	Oppenheimer
6/30/2021	$38.00 → $32.00	Buy	Roth Capital